WallStreetZenWallStreetZen

NASDAQ: GPCR
Structure Therapeutics Inc Stock Ownership - Who owns Structure Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Structure Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ashley HallChief Development Officer2025-09-186,021$7.74
$46.62kSell
Crespo Blas CollCHIEF MEDICAL OFFICER2025-09-188,106$7.74
$62.76kSell
Yingli MaCHIEF TECHNOLOGY OFFICER2025-07-014,470$6.84
$30.56kSell
Jun YoonCHIEF FINANCIAL OFFICER2025-07-017,089$6.84
$48.47kSell
Xichen LinCHIEF SCIENTIFIC OFFICER2025-07-0112,846$6.84
$87.83kSell
Crespo Blas CollCHIEF MEDICAL OFFICER2025-07-011,434$6.84
$9.80kSell
Raymond C. StevensCHIEF EXECUTIVE OFFICER2025-07-0116,050$6.84
$109.73kSell
Yingli MaCHIEF TECHNOLOGY OFFICER2025-03-011,824$7.92
$14.44kSell
Xichen LinCHIEF SCIENTIFIC OFFICER2025-03-016,441$7.92
$50.99kSell
Crespo Blas CollCHIEF MEDICAL OFFICER2025-03-011,233$7.92
$9.76kSell

1 of 2

GPCR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GPCR insiders and whales buy or sell their stock.

GPCR Shareholders

What type of owners hold Structure Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wellington Management Group LLP3.98%6,875,769$229.10MInstitution
Fil Ltd3.75%6,473,761$215.71MInsider
Fmr LLC3.09%5,345,338$178.11MInsider
Deep Track Capital LP2.97%5,133,917$171.06MInstitution
Fmr LLC2.84%4,914,965$163.77MInstitution
Janus Henderson Group PLC2.65%4,573,006$152.37MInstitution
Ramy Farid1.89%3,260,495$108.64MInsider
Jun Yoon1.66%2,874,462$95.78MInsider
Raymond C. Stevens1.59%2,749,416$91.61MInsider
Baker Bros Advisors LP1.45%2,508,767$83.59MInstitution

1 of 3

GPCR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GPCR31.63%12.59%Net SellingNet Selling
EWTX88.36%11.64%Net BuyingNet Selling
VRDN75.25%24.75%Net BuyingNet Buying
BHVN81.99%18.01%Net Buying
VERA66.54%33.46%Net Buying
View Top Biotech Stocks

Structure Therapeutics Stock Ownership FAQ

Who owns Structure Therapeutics?

Structure Therapeutics (NASDAQ: GPCR) is owned by 31.63% institutional shareholders, 12.59% Structure Therapeutics insiders, and 55.79% retail investors. Fil Ltd is the largest individual Structure Therapeutics shareholder, owning 6.47M shares representing 3.75% of the company. Fil Ltd's Structure Therapeutics shares are currently valued at $215.71M.

If you're new to stock investing, here's how to buy Structure Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.